Status:
COMPLETED
Virtual Ileostomy Versus Diverting Ileostomy
Lead Sponsor:
fan li
Conditions:
Rectal Cancer
Eligibility:
All Genders
18+ years
Brief Summary
This study aimed at comparing the Comprehensive Complication Index (CCI), readmission rates, postoperative hospitalization days, duration of bearing the stoma (months), hospitalization costs, the numb...
Detailed Description
Diverting ileostomy (DI) is a common procedure performed in patients undergoing total mesorectal excision for rectal cancer to protect the anastomosis and reduce the risk of complications. Although DI...
Eligibility Criteria
Inclusion
- Diagnosis of rectal cancer confirmed by pathology
- Age ≥ 18 years
- Lap/robot total mesorectal excision (TME) surgical procedures and colon-rectum or colon-anal anastomosis#1.anterior resection (AR/ PME), 2. low anterior resection (LAR) , 3.intersphincteric abdominoperineal resection (ISR), 4.transanal total mesorectal excision (TaTME)
- Ability to understand the nature and risks of participating in the trial
Exclusion
- Emergency surgery, open surgery
- ASA score \>3points
- Patients with combined complete intestinal obstruction
- Long-term history of using immunosuppressants or glucocorticoids
- Combined severe cardiac disease: with congestive heart failure or NYHA cardiac function ≥ grade 2. Patients with a history of myocardial infarction or coronary artery surgery within 6 months before the procedure
- Chronic renal failure (requiring dialysis or glomerular filtration rate \<30 mL/ min)
- Intraoperative combined multi-organ resection
- Combined cirrhosis of the liver
- Intraoperative findings of incomplete anastomosis and positive insufflation test
- missing information
Key Trial Info
Start Date :
January 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
October 12 2024
Estimated Enrollment :
612 Patients enrolled
Trial Details
Trial ID
NCT05985239
Start Date
January 1 2023
End Date
October 12 2024
Last Update
October 15 2024
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Daping Hospital, Third Military Medical University
Chongqing, China, 400042